Tag: Vaccines
Benefits of Maternal Immunization Against Group B Strep Explored
Net monetary benefit from group B Streptococcus vaccination estimated to range from $1.1 to $17 billion
Antibody Response Prolonged With COVID-19 Vaccine-Associated Symptoms
Increased likelihood of experiencing prolonged neutralizing antibody response seen for those with vaccine-associated symptoms, prior SARS-CoV-2 infection
Age, Cancer Type Affect COVID-19 Vaccine Uptake in Cancer Patients
Higher rates of vaccination seen in older patients; lower rates seen for metastatic solid tumors, with comorbidities
Axillary Lymphadenopathy Resolves at Mean 102 Days After COVID-19 Booster
No significant associations seen for age, vaccine booster type, history of breast cancer with time to resolution
ACC: COVID-19 Vaccination Cuts Risk for Cardiac Events With SARS-CoV-2 Infection
Findings significant for both partial and complete COVID-19 vaccination
FDA Panel Backs Second RSV Vaccine for Older Americans
In two-part vote, panel voted 10 to 2 in favor of the vaccine's safety and unanimously on the shot's effectiveness
FDA Panel Backs Pfizer RSV Vaccine for Older Americans
Pfizer has reported that its vaccine would reduce risk from RSV by as much as 86 percent
Flu Vaccine Effective for 2022/2023 Season
Vaccine effectiveness 54 percent against medically attended outpatient acute respiratory infection associated with influenza A in patients younger than 65 years
Parents Weigh Complex Factors in COVID-19 Vaccination Decisions
Parents report a mix of factors, including scientific evidence and political and social pressures, influencing their decision
Single Dose of RSV Vaccine Prevents Acute Respiratory Infection in Seniors
High vaccine efficacy seen against RSV A and B subtypes, across age groups among those aged 60 years and older, and for those with coexisting conditions
